An Open-Label Study of Aripiprazole to Evaluate the Safety and Tolerability in Patients With Psychosis Associated With Parkinson's Disease
Phase of Trial: Phase IV
Latest Information Update: 08 Jun 2009
At a glance
- Drugs Aripiprazole (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 08 Jun 2009 Status changed from active, no longer recruiting to completed.
- 08 Jun 2009 New trial record.